Lux Capital partners Adam Goulburn and Zavain Dar expect pharma companies to build out new ways to reach consumers, perhaps by acquiring a direct-to-consumer healthcare business.
As pharmaceutical companies look to revamp their businesses, getting direct access to costumers and better using artificial intelligence in drug development could be key pieces.
The goal for pharma companies, Dar said, is to figure out, "How do we make sure we don't get disrupted?"
Subscribe to Dispensed, Business...
Read this story at Business Insider